Literature DB >> 15630037

Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.

Hans-Ruprecht Neuberger1, Ulrich Schotten, Sander Verheule, Sabine Eijsbouts, Yuri Blaauw, Arne van Hunnik, Maurits Allessie.   

Abstract

BACKGROUND: Atrial dilatation is an important risk factor for atrial fibrillation (AF). In the present study, we monitored the electrophysiological changes during progressive atrial dilatation in chronically instrumented goats. METHODS AND
RESULTS: In 8 goats, 2 screw-in leads with piezoelectric crystals were implanted transvenously in the right atrium. After 2 weeks, atrial diameter and effective refractory period were measured. AF paroxysms were induced by burst pacing to determine the baseline AF cycle length and stability of AF. After His-bundle ablation, the above measurements were repeated once a week. After 4 weeks of complete AV block, the free wall of the right atrium was mapped and the atrium was fixed in formalin for histological analysis. After His-bundle ablation, the ventricular rate decreased from 113.8+/-4.8 to 44.6+/-2.5 bpm. Right atrial diameter increased gradually by 13.5+/-3.9% during 4 weeks of AV block (P<0.01). The duration of induced AF paroxysms increased from 4.6 seconds to 6.4 minutes (P<0.05). Atrial effective refractory period and AF cycle length remained constant. Spontaneous paroxysms of AF were not observed. Atrial mapping during rapid pacing revealed that slow conduction (<30 cm/s) was present in 3.7+/-1.0% of the mapped area (control, 0.9+/-0.5%, P<0.05). Histological analysis showed hypertrophy without atrial fibrosis. Connexin40 and connexin43 expression was unchanged.
CONCLUSIONS: Chronic AV block in the goat leads to progressive atrial dilatation, prolongation of induced AF paroxysms, and local conduction delays. The increase in AF stability was not a result of a shortening of atrial refractoriness or atrial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630037     DOI: 10.1161/01.CIR.0000151517.43137.97

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

Review 3.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

4.  Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study.

Authors:  V Simopoulos; G Tagarakis; A Hatziefthimiou; I Skoularigis; F Triposkiadis; V Trantou; N Tsilimingas; I Aidonidis
Journal:  Clin Res Cardiol       Date:  2014-08-19       Impact factor: 5.460

Review 5.  Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

Authors:  A J Workman; G L Smith; A C Rankin
Journal:  Pharmacol Ther       Date:  2011-02-18       Impact factor: 12.310

6.  Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.

Authors:  Alexander Burashnikov; Marc Pourrier; John K Gibson; Joseph J Lynch; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-02-09

7.  Pulmonary venous structural remodeling in a canine model of chronic atrial dilation due to mitral regurgitation.

Authors:  Qi Sun; Min Tang; Jielin Pu; Shu Zhang
Journal:  Can J Cardiol       Date:  2008-04       Impact factor: 5.223

Review 8.  Atrial fibrillation in heart failure: current treatment of patients with remodeled atria.

Authors:  Hans-Ruprecht Neuberger; Jan-Christian Reil; Oliver Adam; Ulrich Laufs; Christian Mewis; Michael Böhm
Journal:  Curr Heart Fail Rep       Date:  2008-12

Review 9.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

10.  Association of common variations on chromosome 4q25 and left atrial volume in patients with atrial fibrillation.

Authors:  Yuliya Mints; Hirad Yarmohammadi; Irfan M Khurram; Hana Hoyt; Rozann Hansford; Stefan L Zimmerman; Steven J Steinberg; Daniel P Judge; Gordon F Tomaselli; Hugh Calkins; Vadim Zipunnikov; Saman Nazarian
Journal:  Clin Med Insights Cardiol       Date:  2015-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.